These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2891857)

  • 1. Heterogeneity of opioid receptor binding in brain slices.
    Barchfeld-Rothschild CC; Medzihradsky F
    J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV; Medzihradsky F
    Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding characteristics of mu and kappa agonists in rat brain subcellular fractions.
    Monferini E; Adler MW; Simon EJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1295-8. PubMed ID: 6128655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution in the receptor binding of putative mu and kappa opiates.
    Medzihradsky F; Dahlstrom PJ; Woods JH; Fischel SV; Mitsos SE
    Life Sci; 1984 May; 34(22):2129-38. PubMed ID: 6145076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
    NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA; Wooten GF
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-dihydromorphine binding sites in subcellular fractions of rat striatum.
    Antkiewicz-Michaluk L; Vetulani J; Havemann U; Kuschinsky K
    Pol J Pharmacol Pharm; 1982; 34(1-3):73-8. PubMed ID: 6300816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo receptor binding of opioid drugs at the mu site.
    Rosenbaum JS; Holford NH; Sadée W
    J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N; Pasternak GW
    Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.
    Pfeiffer A; Herz A
    Mol Pharmacol; 1982 Mar; 21(2):266-71. PubMed ID: 6124875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW; West RE; Miller RJ; Dawson G
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of opiate receptors using intrinsically photoactive 3H-opiates.
    Kooper GN; Levinson NR; Copeland CF; Bowen WD
    Mol Pharmacol; 1988 Mar; 33(3):316-26. PubMed ID: 2832721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.